leisure time -WSS

leisure time

author：comprehensive 2025-08-30 11:02:09 - browse：995

Adam's take main illustration — Molly Ferguson/STAT

For two days starting on Sunday, Moonlake Immunotherapeutics happily crunched numbers and shared results from a mid-stage clinical trial that depicted its experimental antibody in the most flattering terms possible.

The drug, called sonelokimab, was “changing the game” for the treatment of a debilitating skin condition called hidradenitis suppurativa, or HS, said Moonlake CEO Jorge Santos da Silva, on a call for investors and analysts. The drug’s benefit for patients placed it “at the top of the heap,” he added.

For other, equally important data from the same study that did not fit Moonlake’s home-run narrative, the company took a DIY approach. Curious about how sonelokimab performed against a treatment that’s already approved for HS? Pull out a calculator and do the math yourself. How badly did a higher dose of the drug underperform a lower dose? Take a guess.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Snackable artificial intelligence, expert AI, and the pharma industry

WSS

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

NIH nominee Bertagnolli will get October confirmation hearing

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

Brazil's Jair Bolsonaro is barred from running for office until 2030

Eating disorder hotline's move to chatbot carried cost for volunteers

The simple reason for the increase in autism diagnosis

knowledge

leisure time

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

Trump surgeon general acknowledges mistakes during Covid

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

Peter Hotez and the public health issue of online harassment

A rare thyroid diagnosis led to unexpected, all

Hollywood unions extend contract negotiations for actors

Stem cell treatment guidelines are released by FDA

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

entertainment

ALS advocates say criticism of new drugs misses bigger picture

Ethical issues complicate the benefits of medical crowdfunding

Why Novartis is changing the name of its research labs

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

Medical experts exlpore how to eliminate bias in clinical algorithms

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

focus

knowledge

focus

Wikipedia